The Operations and Clinical Assessment Core (OCAC) fulfills the required core described in the CIDAR Program Announcement (PA05-039). The OCAC will serve three major functions: 1) overall center administration;2) subject recruitment and assessment;and 3) database management and statistical analysis. Consequently, the OCAC has been divided into three divisions corresponding with these major functions. Each division has a director specifically assigned to ensure that the goals and objectives for that division are met;these directors report to Dr. Strakowski, who will serve as OCAC director, in addition to his role as overall BITREC director. The Administrative Division will provide overall management of the BITREC; to achieve this goal it will be composed of the BITREC director, a Steering Committee, two external advisory committees and administrative personnel. Dr. Strakowski will direct this division, consistent with his roles as OCAC and BITREC director. The Clinical Assessment and Recruitment Division (CARD) of the OCAC will provide patient recruitment, informed consent and human subjects regulatory functions, and initial assessments. We have chosen to centralize these functions in order to integrate projects and to maintain consistent subject management and evaluations across projects. Dr. DelBello will direct the CARD. The Biostatistics Division (BD) is included in the OCAC as required by the CIDAR program announcement, although, given the central role of Biostatistics in this center, this division will, in many ways, function as a core. The Biostatistics Division will be a central resource used by all projects and cores. This division will provide expertise in the translation of clinical hypotheses into testable statistical hypotheses, selection of efficient study designs and measurement protocols, estimation of sample size requirements, acquisition and management of data, statistical analysis, and final report preparation. The Biostatistics Division will be codirected by Drs. Succop and Arndt. The divisions of the OCAC will provide organizing and integrating functions over all of the remaining cores and projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH077138-04
Application #
8099708
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2010-07-01
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
4
Fiscal Year
2010
Total Cost
$631,119
Indirect Cost
Name
University of Cincinnati
Department
Type
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Nery, Fabiano G; Norris, Matthew; Eliassen, James C et al. (2017) White matter volumes in youth offspring of bipolar parents. J Affect Disord 209:246-253
Fleck, David E; Ernest, Nicholas; Adler, Caleb M et al. (2017) Prediction of lithium response in first-episode mania using the LITHium Intelligent Agent (LITHIA): Pilot data and proof-of-concept. Bipolar Disord 19:259-272
Welge, Jeffrey A; Saliba, Lawrence J; Strawn, Jeffrey R et al. (2016) Neurofunctional Differences Among Youth With and at Varying Risk for Developing Mania. J Am Acad Child Adolesc Psychiatry 55:980-989
Strakowski, Stephen M; Fleck, David E; Welge, Jeffrey et al. (2016) fMRI brain activation changes following treatment of a first bipolar manic episode. Bipolar Disord 18:490-501
McNamara, Robert K; Jandacek, Ronald; Tso, Patrick et al. (2016) Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker. Early Interv Psychiatry 10:203-11
McNamara, Robert K; Moser, Ann B; Jones, Richard I et al. (2016) Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits. Psychiatry Res 246:803-807
McNamara, Robert K; Jandacek, Ronald; Tso, Patrick et al. (2015) First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine. Psychiatry Res 230:447-53
Jacob, Shawna N; Shear, Paula K; Norris, Matthew et al. (2015) Impact of functional magnetic resonance imaging (fMRI) scanner noise on affective state and attentional performance. J Clin Exp Neuropsychol 37:563-70
Strawn, Jeffrey R; Adler, Caleb M; McNamara, Robert K et al. (2014) Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study. Bipolar Disord 16:523-30
Cerullo, Michael A; Eliassen, James C; Smith, Christopher T et al. (2014) Bipolar I disorder and major depressive disorder show similar brain activation during depression. Bipolar Disord 16:703-12

Showing the most recent 10 out of 28 publications